Green LifeScience Co Ltd

Green LifeScience Co Ltd maintains a strong liquidity position with KRW 13.4 billion in cash and equivalents, representing 24.5% of total assets, and a current ratio of 2.04, which is above the median for the Pharmaceuticals & Medical Research sector. The company's price-to-book ratio of 1.44 and debt-to-equity ratio of 0.18 indicate a conservative capital structure with limited leverage. The company's profitability metrics are weak, with a net income of KRW 110.1 million and a return on equity of 0.29%, both below the sector median. The operating loss of KRW 1.15 billion highlights operational inefficiencies, and the gross profit margin of 6.1% is significantly lower than the industry average of 15.3%. Green LifeScience Co Ltd's revenue is distributed across domestic and international markets, with disclosed exports to Japan, the United States, and Europe. However, the company does not provide segment-specific revenue data, making it difficult to assess geographic concentration risk. The lack of detailed segment reporting is a limitation in evaluating exposure to regional economic shifts. The company's growth trajectory is uncertain, with no disclosed revenue growth in the latest period and a negative free cash flow of KRW 263 million. Capital expenditures of KRW 1.16 billion suggest ongoing investment in operations, but the absence of clear growth drivers or market expansion plans limits visibility into future revenue potential. Risk factors include the company's low liquidity risk score and the absence of immediate dilution threats, as no filing-based flags were detected. However, the high price-to-earnings ratio of 499.84 and negative EBITDA multiple of -42.20 suggest valuation concerns, particularly given the weak profitability and lack of clear growth catalysts. Recent events include the company's rebranding from KPX Lifescience Co Ltd, which may reflect a strategic shift in focus or branding. No recent filings or transcripts were provided in the input data to assess management commentary or strategic direction.